American Century Companies’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.3K Buy
+30,556
New +$65.2K ﹤0.01% 2788
2025
Q2
Sell
-39,525
Closed -$50.2K 2907
2025
Q1
$50.2K Buy
39,525
+27,782
+237% +$72.6K ﹤0.01% 2863
2024
Q4
$38.2K Buy
+11,743
New +$42.3K ﹤0.01% 2877
2024
Q2
Sell
-63,428
Closed -$934K 2915
2024
Q1
$934K Buy
63,428
+12,062
+23% +$182K ﹤0.01% 2179
2023
Q4
$494K Buy
+51,366
New +$355K ﹤0.01% 2361
2023
Q3
Sell
-11,088
Closed -$59.3K 2878
2023
Q2
$59.3K Sell
11,088
-7,177
-39% -$44.3K ﹤0.01% 2754
2023
Q1
$130K Buy
18,265
+3,473
+23% +$20.9K ﹤0.01% 2503
2022
Q4
$99.3K Buy
+14,792
New +$81.1K ﹤0.01% 2456
2015
Q4
Sell
-22,274
Closed -$477K 1350
2015
Q3
$477K Buy
+22,274
New +$699K ﹤0.01% 1217

Other funds holding MGNX

American Century Companies's MGNX Position: Q1 2026 in Review

American Century Companies opened a new position in MacroGenics (MGNX) in Q1 2026: 30,556 shares worth $88.3K. The stake represents ﹤0.01% of the portfolio and ranks #2788 among its holdings. This is a return to the name: American Century Companies previously reported a position in MGNX as recently as Q1 2025.

American Century Companies first reported a position in MGNX in Q3 2015 and has held it in 9 quarters since. The position peaked at $934K in Q1 2024. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • American Century Companies held 30,556 shares of MacroGenics worth $88.3K as of Q1 2026.
  • MacroGenics was a new American Century Companies position in Q1 2026.
  • MacroGenics made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2788 holding.
  • American Century Companies first reported a position in MacroGenics in Q3 2015 and has held it in 9 quarters since.
  • American Century Companies's MacroGenics position peaked at $934K in Q1 2024.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.